Share
people may reject your idea, but you have to keep confident and believe in your solution and that you can make it happen.
Dr. Shakar
Our founder and CTO, Dr. Shakar Jafari blogs in Huffington Post about Women in Innovation and how it is possible to improve cancer care and patients’ quality of life. For more go to huffingtonpost
Related Posts
TRUEinvivo joined SyndicateRoom investment platform in February 2019, leveraging its network to connect with potential investors, alongside Nexus Investment Ventures Ltd,
TRUEinvivo® is pleased to announce that the patent for the DOSEmapper™ TLD bead strings and Automated DOSEmapper™ TLD Reader was granted in the EU on 6th January 2021
TrueInvivo enhances cancer care with accurate, high-resolution in-vivo dosimetry system, optimizing radiotherapy outcomes.
TRUEinvivo's DOSEmapper™ technology receives enthusiastic feedback from industry leaders at ESTRO37 conference.
